Assembly Biosciences Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Assembly Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $50. The average 1-year stock price forecast is 86.99% higher than the current stock price, while the lowest is $43 (+60.81%) and the highest is $62 (+131.86%).

Price Target: $50 (+86.99%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$43	$50	$47.5	$62
Change	+60.81%	+86.99%	+77.64%	+131.86%

Analyst Ratings

The average analyst rating for Assembly Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	4	4	4	4	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Salim Syed Mizuho Securities	Mizuho Securities	Buy Maintains $40 → $45	Buy	Maintains	$40 → $45	+68.29%	Jun 12, 2026
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Reiterates $50	Buy	Reiterates	$50	+86.99%	Jun 4, 2026
Vamil Divan Guggenheim	Guggenheim	Buy Reiterates $43	Buy	Reiterates	$43	+60.81%	May 28, 2026

Financial Forecast

Revenue This Year

57.96M

from 72.30M

-19.84%

from 72.30M

Revenue Next Year

32.25M

from 57.96M

-44.36%

from 57.96M

EPS This Year

0.14

from -0.55

EPS Next Year

-2.11

from 0.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.25M	-	7.16M	28.52M	72.30M	57.96M
Revenue Growth	-92.09%	-	-	298.16%	153.52%	-19.84%
Gross Profit	-63.90M	-69.08M	-41.74M	-27.41M	7.49M	57.96M
Gross Margin	-1,021.67%	-	-582.67%	-96.12%	10.36%	100.00%
Operating Income	-92.40M	-93.01M	-64.65M	-45.42M	-12.12M	-28.19M
Net Income	-129.86M	-93.09M	-61.23M	-40.18M	-6.12M	-20.46M
EPS	-	-	-	-	-0.55	0.14
Forward PE	-	-	-	-	-	191.00
Free Cash Flow	-62.75M	-48.91M	-8.20M	-15.71M	-4.98M	-2.80M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	110.9M
Avg	58.0M
Low	24.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	53.4%
Avg	-19.8%
Low	-66.5%

EPS Forecast

EPS	2026	2027	2028
High	1.90
Avg	0.14
Low	-1.62

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-